Surrozen
$28.2
12
+$0.75+2.73% Today
Statistics
Day High
28.46
Day Low
26.5
52W High
29.99
52W Low
5.9
Volume
215,976
Avg. Volume
105,122
Mkt Cap
241.7M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
13MayExpected
Expected EPS
-1.0525
Actual EPS
N/A
Financials
-596.56%Profit Margin
Unprofitable21.31MRevenue
-127.13MNet Income
Analyst Ratings
$38.00Average Price Target
The highest estimate is 40.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SRZN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Vertex Pharmaceuticals
VRTX
Mkt Cap111.43B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.67B
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.29B
CRISPR Therapeutics
CRSP
Mkt Cap4.75B
Novartis
NVS
Mkt Cap297.32B
Pfizer
PFE
Mkt Cap161.09B
Gilead Sciences
GILD
Mkt Cap173.41B
About
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Show more...
CEO
Mr. Craig C. Parker M.B.A.
Employees
40
Country
US
ISIN
US86889P2083
Listings
0 Comments
Share your thoughts
FAQ
What is Surrozen stock price today?▼
The current price of SRZN is $28.2 USD — it has increased by +2.73% in the past 24 hours. Watch Surrozen stock price performance more closely on the chart.
What is Surrozen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Surrozen stocks are traded under the ticker SRZN.
Is Surrozen stock price growing?▼
SRZN stock has risen by +1.18% compared to the previous week, the month change is a +1.66% rise, over the last year Surrozen has showed a +207.52% increase.
What is Surrozen market cap?▼
Today Surrozen has the market capitalization of 241.7M
When is the next Surrozen earnings date?▼
Surrozen is going to release the next earnings report on May 13, 2026.
What were Surrozen earnings last quarter?▼
SRZN earnings for the last quarter are -19.13 USD per share, whereas the estimation was -1.29 USD resulting in a -1,385.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Surrozen revenue for the last year?▼
Surrozen revenue for the last year amounts to 21.31M USD.
What is Surrozen net income for the last year?▼
SRZN net income for the last year is -127.13M USD.
How many employees does Surrozen have?▼
As of April 10, 2026, the company has 40 employees.
In which sector is Surrozen located?▼
Surrozen operates in the Health Care sector.
When did Surrozen complete a stock split?▼
The last stock split for Surrozen was on December 14, 2023 with a ratio of 1:15.
Where is Surrozen headquartered?▼
Surrozen is headquartered in South San Francisco, US.